Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | SVASinovac Biotech LtdFY2025 · Dec |
|---|---|
| Revenue | $386.01M |
| Revenue, yoy | +6.8% |
| Net income | $198.84M |
| Net income, yoy | −589.1% |
| Net margin | -51.5% |
| Free cash flow | $561.10M |
| FCF margin | -145.4% |
| EPS, diluted | $0.83 |
Add another company.